Characterisation of the Novel HLA‐DRB3*01:127 Allele by Next‐Generation Sequencing
HLA · 2026-09 · 108 (3)
DOI: 10.1111/tan.70926 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, online erschienen am 29.08.2026. Verfasst von Wenwen Pi und 4 weiteren Autor:innen. Beteiligte Einrichtung: HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China. Hauptthemen laut MEDLINE: Alleles, Exons, HLA-DRB3 Chains, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Medical and Health Science Program of Zhejiang Province.
Abstract (Originalsprache)
HLA‐DRB3*01:127 differs from the HLA‐DRB3*01:01:02:01 allele by one nucleotide substitution in the exon 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.
ORCID-Profile: Wenwen Pi, Lina Dong, Qi Li, Wei Zhang, Faming Zhu
Förderung
- the Medical and Health Science Program of Zhejiang Province
Zitieren
APA
Pi, W., Dong, L., Li, Q., Zhang, W., & Zhu, F. (2026). Characterisation of the Novel HLA‐DRB3*01:127 Allele by Next‐Generation Sequencing. HLA, 108(3). https://doi.org/10.1111/tan.70926
Vancouver
Pi W, Dong L, Li Q, Zhang W, Zhu F. Characterisation of the Novel HLA‐DRB3*01:127 Allele by Next‐Generation Sequencing. HLA. 2026;108(3). doi:10.1111/tan.70926
BibTeX
@article{Pi2026,
author = {Pi, Wenwen and Dong, Lina and Li, Qi and Zhang, Wei and Zhu, Faming},
title = {Characterisation of the Novel HLA‐DRB3*01:127 Allele by Next‐Generation Sequencing},
journal = {HLA},
year = {2026},
volume = {108},
number = {3},
doi = {10.1111/tan.70926}
}
EUVIMED